DEUCRAVACITINIB

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H22N8O3
Molecular Weight	425.459
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[2H]C([2H])([2H])NC(=O)C1=C(NC2=CC=CC(C3=NN(C)C=N3)=C2OC)C=C(NC(=O)C4CC4)N=N1

InChI

InChIKey=BZZKEPGENYLQSC-FIBGUPNXSA-N

InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3

HIDE SMILES / InChI

Approval Year

Name

Type

Language

DEUCRAVACITINIB

Official Name

English

6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(2H3)METHYL-3-PYRIDAZINE-CARBOXAMIDE

Systematic Name

English

Deucravacitinib [WHO-DD]

Common Name

English

DEUCRAVACITINIB [JAN]

Common Name

English

DEUCRAVACITINIB [USAN]

Common Name

English

3-PYRIDAZINECARBOXAMIDE, 6-((CYCLOPROPYLCARBONYL)AMINO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)-

Systematic Name

English

BMS-986165

Common Name

English

SOTYKTU

Brand Name

English

deucravacitinib [INN]

Common Name

English

Code System Code Type Description

FDA UNII

N0A21N6RAU